BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen B. Managing medical complications and recurrence after surgery for Crohn’s disease. Curr Gastroenterol Rep 2008;10:606-11. [DOI: 10.1007/s11894-008-0109-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
Number Citing Articles
1 Mosli MH, Feagan BG. Vedolizumab for Crohn’s disease. Expert Opin Biol Ther. 2013;13:455-463. [PMID: 23394379 DOI: 10.1517/14712598.2013.770835] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
2 Ren J, Wu X, Liao N, Wang G, Fan C, Liu S, Ren H, Zhao Y, Li J. Prevention of postoperative recurrence of Crohn's disease: Tripterygium wilfordii polyglycoside versus mesalazine. J Int Med Res 2013;41:176-87. [PMID: 23569144 DOI: 10.1177/0300060512474744] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]